Class Action

Wal-Phed PE Nasal Decongestant Tablets

Class Action

Wal-Phed PE Nasal Decongestant Tablets


Case Name (Date)

Rampalli et al. v. Walgreen Co.
23-cv-14015, N.D. Ill.
(Sept. 2023)


Product/Service

Wal-Phed PE Nasal Decongestant Tablets


Allegations

Falsely marketing that medicines relieve sinus pressure and congestion when the active ingredient (phenylephrine) is not an effective decongestant


Status

Pending



Class-Action Tracker

Walgreens Acne Products

Class Action

Walgreens Acne Products

Allegations: Misleadingly representing that products were safe when they contain, or were at risk of containing, the carcinogen benzene

Several Store Brand Acetaminophen Products

Class Action

Several Store Brand Acetaminophen Products

Allegations: Marketing products as safe pain relievers for pregnant women without warning consumers that scientific evidence shows prenatal exposure to APAP can cause neurodevelopmental disorders in children

Walgreens’ Infants’ Pain & Fever Acetaminophen

Class Action

Walgreens’ Infants’ Pain & Fever Acetaminophen

Allegations: Misleadingly marketing its infants’ product as specifically formulated for infants and different from its Children’s Pain & Fever Acetaminophen Oral Suspension when both medications contain the same amount and…


The Latest

Filters


Show More